Trials / Completed
CompletedNCT03086304
Effects of Transcutaneous Acupoint Electrical Stimulation on Intestinal Obstruction After Gastrointestinal Surgery
Effects of Transcutaneous Acupoint Electrical Stimulation on Intestinal Obstruction After Gastrointestinal Surgery in Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 610 (actual)
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Postoperative intestinal obstruction (POI) is one of the most common complications in the gastrointestinal surgery. Compared with the conventional control group, transcutaneous acupoint electrical stimulation(TEAS) is possible to reduce the incidence of POI and accelerate the rapid recovery of the gastrointestinal tract.
Detailed description
Participants will be randomly assigned, in a 1:1 ratio, to receive TEAS or Blank treatment (acupoints selection are same with the experimental group, connect stimulator for patients, but not don't give stimulus). The randomization sequence will be computer-generated, and randomization will be performed in blocks and will be stratified according to participating center. TEAS will be performed in a series of time periods after operation. Time of first fart and food-taking ,time of have normal diet after the transplantation will be recorded. The participation of each patient is scheduled for 30 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | transcutaneous acupoint electrical stimulation | Transcutaneous acupoint electrical stimulation is same to the traditional Chinese medicine acupuncture treatment,treat diseases by stimulate different acupuncture points. |
| DEVICE | no transcutaneous acupoint electrical stimulation | the choice of acupoints are same with TEAS group,tape over the electrode but don't give electroacupuncture stimulation. |
Timeline
- Start date
- 2018-05-28
- Primary completion
- 2019-09-03
- Completion
- 2019-09-30
- First posted
- 2017-03-22
- Last updated
- 2019-11-19
Locations
10 sites across 1 country: China
Source: ClinicalTrials.gov record NCT03086304. Inclusion in this directory is not an endorsement.